Prevalence of Stool Outlet Obstruction After Laparoscopic Sacrocolpopexie
Launched by KANTONSSPITAL AARAU · Sep 11, 2018
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
The (pre-) sacral space is characterized by a complex neuroanatomy and surgical intervention in this part of the body is often associated with the dissection of nerve bundels, a procedure which may finally lead to transient defecatory dysfunction. In a earlier study we could show that \~17.8% of patient with laparoscopic sacrocolpopexie developed postoperative constipation within 3-6 months. In november 2010 the Frauenklinik Aarau introduced a novel, nerve-sparing technique of laparoscopic sacrocolpopexie. In this study we assess the pre-and postoperative differences in defecatory dysfuncti...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women affected by symptomatic vault prolapse, who underwent laparoscopic sacrocolpopexy at the KSA
- • informed consent
- Exclusion Criteria:
- • participation in other studies
- • Sacrocolpopexie done by Da Vinci Roboter
- • Patients who had a conversion to laparotomy perioperatively
- • Patients with a recurrence who had to undergo a second surgery
- • Patients who had a relaps operation
About Kantonsspital Aarau
Kantonsspital Aarau is a leading healthcare institution in Switzerland, renowned for its commitment to high-quality patient care and innovative medical research. As a prominent clinical trial sponsor, the hospital actively engages in advancing medical knowledge through rigorous clinical studies that adhere to ethical standards and regulatory guidelines. With a multidisciplinary team of experienced healthcare professionals and researchers, Kantonsspital Aarau fosters collaborative partnerships aimed at developing new therapeutic interventions and improving health outcomes. The institution is dedicated to enhancing clinical practice through evidence-based research, thereby contributing to the advancement of medical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Dimitri Sarlos, PD Dr. med.
Principal Investigator
Kantonsspital Aarau
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials